Internet Of Things, Philanthropist

Jason Hope Advocates for Longevity and Anti-Aging

For decades, stem cell research has elicited mixed reactions across the board. According to others, stem cell research is the future of eradicating diseases. Others, however, continue to protest against the use of this technology on ethical grounds. Jason Hope, a renowned philanthropist, and advocate for stem cell research is optimistic that this genre is here for the long haul. Today, we’re witnessing an increasing number of stem cell research startups and biotech firms opening up (Openthenews). 

 

Stem Cell Research is Born!

Twenty years ago, scientists reported that they had successfully grown cells from human embryonic stem cells due to years of research. This development sent ripples in the medical arena. Researchers knew it would only be a matter of time before creating an anti-aging treatment. According to Jason Hope, the breakthrough had great promise in creating a regenerative treatment for specific diseases like Parkinson’s, stroke, and Alzheimer’s. Today, researchers are yet to release a tested and proven therapy to deal with specific diseases of aging. To date, the only medically accepted applications involve the culturing of blood cells to treat patients with blood anomalies. 

 

 

Jason Hope

About SENS 

Jason Hope argues that a lot more stem cell research needs to take place for us to gain maximum benefits. He’s an active contributor to stem cells researchers at the Strategies for Engineered Negligible Senescence (SENS) group. Jason’s contributions have allowed SENS to fast-track stem cell research and testing. 

 

SENS focuses on preventing the onset of specific diseases like Parkinson’s as opposed to treating its symptoms. The organization is working on retinal cells generation for transplants. Jason’s vision is that we all experience increasing health as we age for quality lives. The philanthropist is, however, critical of the general public’s pervasive distrust of gene therapy. The longevity expert cautions biotech firms from rushing the research and testing ostensibly to release new treatments. To Jason Hope, safety and efficiency always come first. 

 

About Jason Hope 

Jason is an investor, futurist, and philanthropist. He is passionate about using stem cells to promote longevity and retard the aging process. Hope is fond of giving talks on IoT and its application to solving human problems. Hope is a Finance alumni from ASU’s W.P Carey School of Business.